Polypill for prevention of cardiovascular diseases

Affiliations

¹ Department of Internal Medicine and Epidemiology, University of Florida College of Public Health and Health Professions, College of Medicine, Gainesville, FL 32610-0238, USA. Electronic address: osama.dasa@medicine.ufl.edu.
² Department of Cardiovascular Medicine, College of Medicine, Penn State Heart and Vascular Institute, Hershey, PA, USA.

Comment

Osama Dasa et al. Lancet. 2020.

. 2020 Feb 8;395(10222):414.

doi: 10.1016/S0140-6736(19)32993-9.

¹ Department of Internal Medicine and Epidemiology, University of Florida College of Public Health and Health Professions, College of Medicine, Gainesville, FL 32610-0238, USA. Electronic address: osama.dasa@medicine.ufl.edu.
² Department of Cardiovascular Medicine, College of Medicine, Penn State Heart and Vascular Institute, Hershey, PA, USA.

No abstract available

Comment in

Polypill for prevention of cardiovascular diseases - Authors' reply.
Roshandel G, Kamangar F, Marshall T, Cheng KK, Hemming K, Malekzadeh R. Roshandel G, et al. Lancet. 2020 Feb 8;395(10222):414-415. doi: 10.1016/S0140-6736(19)32966-6. Lancet. 2020. PMID: 32035547 No abstract available.

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, Ostovaneh MR, Nateghi A, Majed M, Navabakhsh B, Merat S, Pourshams A, Nalini M, Malekzadeh F, Sadeghi M, Mohammadifard N, Sarrafzadegan N, Naemi-Tabiei M, Fazel A, Brennan P, Etemadi A, Boffetta P, Thomas N, Marshall T, Cheng KK, Malekzadeh R. Roshandel G, et al. Lancet. 2019 Aug 24;394(10199):672-683. doi: 10.1016/S0140-6736(19)31791-X. Lancet. 2019. PMID: 31448738 Clinical Trial.